Mirae Asset Global ETFs Holdings
IMRX icon

Mirae Asset Global ETFs Holdings’s Immuneering IMRX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,627
Closed -$51.3K – 3153
2025
Q4 		$51.3K Buy
+7,627
New +$49K ﹤0.01% 2929
2024
Q3 		– Sell
-11,389
Closed -$14.6K – 3129
2024
Q2 		$14.6K Buy
+11,389
New +$18.7K ﹤0.01% 2942

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's IMRX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Immuneering (IMRX) in Q1 2026, closing a stake of 7,627 shares — an estimated $51.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in IMRX in Q2 2024 and held it in 2 quarters. The position peaked at $51.3K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Immuneering position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 7,627 Immuneering shares in Q1 2026, an estimated $51.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in Immuneering in Q2 2024 and held it in 2 quarters.
  • Mirae Asset Global ETFs Holdings's Immuneering position peaked at $51.3K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.